Strategic partnerships Leverage Sarah Cannon's recent collaboration with Texas Oncology and ongoing transplant/network expansion to propose joint programs, shared research initiatives, and co-branded patient navigation services across regional markets.

Clinical trial expansion Position to support SCRI with expanded outsourcing of clinical trial operations, data management, and patient recruitment leveraging Sarah Cannon’s large patient network and ongoing hundreds of trials.

CAR-T & post-care Offer solutions for outpatient CAR-T monitoring tools, remote patient monitoring, and follow-up care pathways to align with Sarah Cannon’s model for monitoring CAR-T recipients and reduce readmissions.

Molecular profiling Introduce advanced molecular profiling services, genomic data integration, and precision oncology workflows to enhance existing therapies and accelerate personalized treatment plans in Sarah Cannon’s network.

Technology enablement Propose scalable IT and data analytics collaborations using familiar tech stack elements (Salesforce, MicroStrategy, Dynatrace) to optimize patient navigation, trial enrollment, and operational efficiency across multiple sites.